Products Ravulizumab was approved in the United States in 2018, in the EU in 2019, and in many countries in 2020 as a concentrate for the preparation of an infusion solution (Ultomiris). Structure and properties Ravulizumab is an IgG2/4K monoclonal antibody produced by biotechnological methods. Effects Ravulizumab (ATC L04AA43) binds to complement protein C5, inhibiting … Ravulizumab
Introduction Lymph node swelling after a dental root canal treatment may indicate an infection related to the previous treatment. Lymph node swelling is initially a very unspecific symptom that has no disease value and only in a few cases results in a disease that requires treatment. In the case of lymph node swelling, irritation of … Lymph node swelling after root canal treatment
When and how must be treated? Root canal treatments in dentistry are associated with a comparatively high risk of infections affecting the bloodstream and involving various organs. For this reason, antibiotic prophylaxis can be administered in advance of treatment to nip any infections in the bud. If lymph node swelling occurs after root canal treatment, … When and how must be treated? | Lymph node swelling after root canal treatment
